Activation of wild-type p53 by MDM2 inhibitors: a new strategy for lymphoma treatment

Anaïs Pujals,1–3,* Loëtitia Favre,4,* Philippe Gaulard,1–3 Joëlle Wiels41Department of Pathology, Assistance Publique-Hôpitaux de Paris, CHU Henri Mondor, 2Faculté de Médecine, Université Paris-Est Cr&eacut...

Full description

Saved in:
Bibliographic Details
Main Authors: Pujals A, Favre L, Gaulard P, Wiels J
Format: article
Language:EN
Published: Dove Medical Press 2015
Subjects:
Online Access:https://doaj.org/article/fd36db5f774b4124b36b99645b5e827a
Tags: Add Tag
No Tags, Be the first to tag this record!